Search research articles
Contact Us
Filters
Showing results (41-50 of 53) with videos related to
Page
of 6
Sort By:
Environmental Health Perspectives
|
June 6, 2025
Expanded Tox21 biological assay panel for the prediction of drug-induced liver injury and cardiotoxicity
Tuan Xu, Masato Ooka, Jinghua Zhao, et al.
Environmental Health Perspectives
|
July 10, 2026
Expanded Tox21 Biological Assay Panel for the Prediction of Drug-Induced Liver Injury and Cardiotoxicity
Tuan Xu, Masato Ooka, Jinghua Zhao, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 28, 2013
Prioritizing genetic testing in patients with Kallmann syndrome using clinical phenotypes
Flavia Amanda Costa-Barbosa, Ravikumar Balasubramanian, Kimberly W Keefe, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 2, 2020
Increased Burden of Rare Sequence Variants in GnRH-Associated Genes in Women With Hypothalamic Amenorrhea
Angela Delaney, Adam B Burkholder, Christopher A Lavender, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 25, 2015
Expanding the Spectrum of Founder Mutations Causing Isolated Gonadotropin-Releasing Hormone Deficiency
Jin-Ho Choi, Ravikumar Balasubramanian, Phil H Lee, et al.
Neurology
|
February 5, 2022
Cross-sectional Neuromuscular Phenotyping Study of Patients With Arhinia With <i>SMCHD1</i> Variants
Payam Mohassel, Ning Chang, Kaoru Inoue, et al.
Journal of Pediatric and Adolescent Gynecology
|
January 15, 2022
The Launch of A Girl's First Period Study: Demystifying Reproductive Hormone Profiles in Adolescent Girls
Janet N Lucien, Madison T Ortega, Madison E Calvert, et al.
Journal of Medical Genetics
|
June 28, 2019
SMCHD1 mutation spectrum for facioscapulohumeral muscular dystrophy type 2 (FSHD2) and Bosma arhinia microphthalmia syndrome (BAMS) reveals disease-specific localisation of variants in the ATPase domain
Richard J L F Lemmers, Nienke van der Stoep, Patrick J van der Vliet, et al.
Neurology
|
July 8, 2018
FSHD type 2 and Bosma arhinia microphthalmia syndrome: Two faces of the same mutation
Karlien Mul, Richard J L F Lemmers, Marjolein Kriek, et al.
Stem Cell Reports
|
June 11, 2026
Scalable hypothalamic neuron differentiation from human pluripotent stem cells suitable for modeling metabolic disorders
Vukasin M Jovanovic, Narisu Narisu, Lori L Bonnycastle, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 53) with videos related to
Sort By:
Page
of 6
Environmental Health Perspectives
|
June 6, 2025
Expanded Tox21 biological assay panel for the prediction of drug-induced liver injury and cardiotoxicity
Tuan Xu, Masato Ooka, Jinghua Zhao, et al.
Environmental Health Perspectives
|
July 10, 2026
Expanded Tox21 Biological Assay Panel for the Prediction of Drug-Induced Liver Injury and Cardiotoxicity
Tuan Xu, Masato Ooka, Jinghua Zhao, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 28, 2013
Prioritizing genetic testing in patients with Kallmann syndrome using clinical phenotypes
Flavia Amanda Costa-Barbosa, Ravikumar Balasubramanian, Kimberly W Keefe, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 2, 2020
Increased Burden of Rare Sequence Variants in GnRH-Associated Genes in Women With Hypothalamic Amenorrhea
Angela Delaney, Adam B Burkholder, Christopher A Lavender, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 25, 2015
Expanding the Spectrum of Founder Mutations Causing Isolated Gonadotropin-Releasing Hormone Deficiency
Jin-Ho Choi, Ravikumar Balasubramanian, Phil H Lee, et al.
Neurology
|
February 5, 2022
Cross-sectional Neuromuscular Phenotyping Study of Patients With Arhinia With <i>SMCHD1</i> Variants
Payam Mohassel, Ning Chang, Kaoru Inoue, et al.
Journal of Pediatric and Adolescent Gynecology
|
January 15, 2022
The Launch of A Girl's First Period Study: Demystifying Reproductive Hormone Profiles in Adolescent Girls
Janet N Lucien, Madison T Ortega, Madison E Calvert, et al.
Journal of Medical Genetics
|
June 28, 2019
SMCHD1 mutation spectrum for facioscapulohumeral muscular dystrophy type 2 (FSHD2) and Bosma arhinia microphthalmia syndrome (BAMS) reveals disease-specific localisation of variants in the ATPase domain
Richard J L F Lemmers, Nienke van der Stoep, Patrick J van der Vliet, et al.
Neurology
|
July 8, 2018
FSHD type 2 and Bosma arhinia microphthalmia syndrome: Two faces of the same mutation
Karlien Mul, Richard J L F Lemmers, Marjolein Kriek, et al.
Stem Cell Reports
|
June 11, 2026
Scalable hypothalamic neuron differentiation from human pluripotent stem cells suitable for modeling metabolic disorders
Vukasin M Jovanovic, Narisu Narisu, Lori L Bonnycastle, et al.
Page
of 6